HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PF-8380 and closely related analogs: synthesis and structure-activity relationship towards autotaxin inhibition and glioma cell viability.

Abstract
A series of PF-8380 analogs, a recently developed autotaxin inhibitor, was explored. Inhibition of autotaxin by these analogs, as well as by all PF-8380 synthetic intermediates, shows the importance of meta-dichlorobenzyl and benzo[d]oxazol-2(3H)-one fragments. However, analogs 8 and 9, bearing only the benzo[d]oxazol-2(3H)-one moiety, are more cytotoxic on the LN229 glioblastoma cell line than PF-8380 and temozolomide (TMZ).
AuthorsPatrick-Denis St-Cœur, Dean Ferguson, Pier Morin Jr, Mohamed Touaibia
JournalArchiv der Pharmazie (Arch Pharm (Weinheim)) Vol. 346 Issue 2 Pg. 91-7 (Feb 2013) ISSN: 1521-4184 [Electronic] Germany
PMID23300119 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Chemical References
  • 6-(3-(piperazin-1-yl)propanoyl)benzo(d)oxazol-2(3H)-one
  • Antineoplastic Agents
  • Benzoxazoles
  • Phosphodiesterase Inhibitors
  • Piperazines
  • Phosphoric Diester Hydrolases
  • alkylglycerophosphoethanolamine phosphodiesterase
Topics
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Benzoxazoles (chemical synthesis, chemistry, pharmacology)
  • Brain Neoplasms (enzymology, pathology)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Drug Design
  • Glioblastoma (enzymology, pathology)
  • Humans
  • Molecular Structure
  • Phosphodiesterase Inhibitors (chemical synthesis, chemistry, pharmacology)
  • Phosphoric Diester Hydrolases (metabolism)
  • Piperazines (chemical synthesis, chemistry, pharmacology)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: